BOT 2.00% 36.8¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-240

  1. 4,176 Posts.
    lightbulb Created with Sketch. 5443
    Correction for you.

    PE on ASX is based on profit, not gross sales EBOTI. So where you say 750 per unit... that is a gross sales price, and need to take all costs out of that first, then apply tax, then use the new figure ( I was using $200 ). And back convert to aud.

    However, agree I think SP will be somewhere in the single digits by next year. I hope the company release the sales data so we can more or less compare success against Kaken.


    Well done to everyone who held over that decision. It took some intestinal fortitude for sure, but in 5 years time I bet everyone will be looking at BOT graph saying, I wish I was able to purchase pre FDA approval!!

    Now it's over to the team to smash sales out of the park. Keep an eye on the influencer scene to see how BOT fares in the marketing next quarter!

    Get it Vince!!!!!




 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.8¢
Change
-0.008(2.00%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.0¢ 36.5¢ $701.8K 1.886M

Buyers (Bids)

No. Vol. Price($)
17 561973 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 318337 11
View Market Depth
Last trade - 11.36am 30/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.